心理社会因素对持续性疼痛患者神经调控治疗成功的影响
前瞻性观察研究纳入60例接受脊髓电刺激试验的持续性疼痛患者,术前完成PROMIS CAT评估。58例成功置入电极者中11例试验失败,失败者术前焦虑、抑郁和睡眠障碍水平更高,成功者术后这些域及疼痛干扰均降低。
要点
- 高水平的抑郁、焦虑和睡眠障碍可预测脊髓电刺激试验失败。
- 试验成功的患者术前焦虑、抑郁和睡眠障碍水平较低。
- PROMIS CAT可用于脊髓电刺激患者筛选评估。
核心结论
- 使用PROMIS CAT评估的高水平抑郁、焦虑和睡眠障碍可预测脊髓电刺激试验失败。
- 脊髓电刺激试验成功的患者在试验结束时报告的抑郁、睡眠障碍和疼痛干扰水平较低。
研究设计与样本
- 前瞻性观察性研究,纳入60例接受脊髓电刺激试验的持续性疼痛患者。
主要发现
- 58例成功置入电极的患者中11例试验失败。
- 试验成功与失败患者之间人口学特征无差异。
- 试验成功患者术前焦虑、抑郁和睡眠障碍水平较低,试验后抑郁、睡眠障碍和疼痛干扰水平降低。
关键数值与推荐
- PROMIS CAT用于测量自报的疼痛干扰、抑郁、焦虑、躯体功能和睡眠障碍。
临床怎么用
- 术前可使用PROMIS CAT评估抑郁、焦虑和睡眠障碍,以辅助筛选脊髓电刺激试验患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Significant interindividual variability in spinal cord stimulation (SCS) outcomes exists. Due to its high cost and risks of complications, criteria to guide patient selection for SCS trials and their outcomes would be helpful. With increased focus on the use of patient-reported outcomes to improve care, we aim to evaluate the National Institute of Health Patient Reported Outcome Measurement Information System measures for an association with successful SCS trials in patients with persistent pain. METHODS: Our prospective, observational study enrolled 60 patients with persistent pain who underwent an SCS trial. Patients completed demographic and Patient Reported Outcome Measurement Information System computer adaptive test (PROMIS CAT) assessments to measure self-reported pain interference, depression, anxiety, physical functioning, and sleep disturbance at the time they presented for placement of their trial device. RESULTS: Of the 58 patients who underwent successful electrode placement, 11 had an unsuccessful trial. There were no differences in patient demographics between patients with a successful and an unsuccessful trial. Patients who had a successful SCS trial reported lower pre-trial levels of anxiety, depression, and sleep disturbance and decreased post-trial levels of depression, sleep disturbance, and pain interference. CONCLUSIONS: We found that patients with high levels of depression, anxiety, and sleep disturbance using the PROMIS CAT were predictive of unsuccessful trials. In addition, we found that patients with successful SCS trials reported lower levels of these domains on PROMIS CAT administered at the end of the trial.
引用
- Goree JH, Payakachat N, Byers L, et al. Impact of psychosocial factors on the success of neuromodulation treatment for patients with persistent pain. Reg Anesth Pain Med. 2024. PMID: 38388016. doi:10.1136/rapm-2023-104962
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。